Invivoscribe competitors

Zippia score 4.2

Invivoscribe main competitors are DXS, Co-Diagnostics, and Moderna.

Competitor Summary. See how Invivoscribe compares to its main competitors:

Ethicon has the most employees (11,000).
Employees at DXS earn more than most of the competitors, with an average yearly salary of $91,848.

Work at Invivoscribe?

Share your experience

Invivoscribe vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Invivoscribe	1995	4.2	San Diego, CA	1	$6.5M	190
Rheonix	2007	4.2	Ithaca, NY	1	$13.3M	82
Molecular epidemiology	-	4.0	Lake Forest Park, WA	1	$14.0M	83
DXS	2001	4.1	-	-	$16.0M	175
Co-Diagnostics	2013	4.1	Salt Lake City, UT	1	$3.9M	20
Integrated DNA Technologies	1987	4.3	Coralville, IA	4	$350.0M	1,558
DxTerity	2006	4.2	East Rancho Dominguez, CA	1	$7.0M	25
AnaSpec	1993	3.9	Fremont, CA	1	$10.0M	50
Ethicon	1915	4.8	Cincinnati, OH	1	$4.9B	11,000
Fresenius Kabi	1996	4.7	Lake Zurich, IL	2	$800.0M	72
Sigma-Aldrich	1951	4.9	Saint Louis, MO	2	$2.8B	9,600
LGC Biosearch Technologies	1993	4.3	Petaluma, CA	1	$75.0M	100
Bio-Techne	1976	4.5	Minneapolis, MN	5	$1.2B	2,250
Moderna	2010	4.8	Cambridge, MA	2	$3.2B	2,500
Instrumentation Laboratory	1959	4.8	Bedford, MA	2	$1.0B	3,000
Biomérieux	1963	4.7	Durham, NC	1	-	6,828
Martek Biosciences	1985	4.4	Columbia, MD	1	$450.0M	600
CIMA Labs	1986	3.9	Eden Prairie, MN	1	$8.5M	120
B. Braun Medical	1839	4.8	Bethlehem, PA	4	$3.3B	4,099
Novel Ingredients	1995	4.1	West Caldwell, NJ	1	$6.3M	75
Immucor	1982	4.8	Norcross, GA	1	$380.0M	1,125

Rate Invivoscribe's competitiveness in the market.

Invivoscribe salaries vs competitors

Among Invivoscribe competitors, employees at DXS earn the most with an average yearly salary of $91,848.

Compare Invivoscribe salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Invivoscribe	$66,281	$31.87	-
Rheonix	$45,262	$21.76	-
Molecular epidemiology	$49,447	$23.77	-
DXS	$91,848	$44.16	-
Co-Diagnostics	$84,265	$40.51	-
Integrated DNA Technologies	$78,325	$37.66	-

Compare Invivoscribe job title salaries vs competitors

Company	Highest salary	Hourly salary
Invivoscribe	$36,511	$17.55
CIMA Labs	$45,521	$21.88
Ethicon	$43,073	$20.71
LGC Biosearch Technologies	$42,105	$20.24
Instrumentation Laboratory	$42,024	$20.20
AnaSpec	$41,955	$20.17
Martek Biosciences	$41,882	$20.14
Biomérieux	$41,184	$19.80
Sigma-Aldrich	$40,703	$19.57
Integrated DNA Technologies	$40,586	$19.51
Molecular epidemiology	$39,321	$18.90
Immucor	$36,887	$17.73
Fresenius Kabi	$36,680	$17.63
Moderna	$36,463	$17.53
DXS	$36,032	$17.32
Rheonix	$35,610	$17.12
DxTerity	$35,601	$17.12
Co-Diagnostics	$35,373	$17.01
B. Braun Medical	$35,183	$16.91
Novel Ingredients	$35,152	$16.90

Do you work at Invivoscribe?

Does Invivoscribe effectively differentiate itself from competitors?

Invivoscribe jobs

Invivoscribe demographics vs competitors

Compare gender at Invivoscribe vs competitors

Job title	Male	Female
Bio-Techne	47%	53%
Immucor	49%	51%
Fresenius Kabi	59%	41%
Invivoscribe	59%	41%
B. Braun Medical	59%	41%
Biomérieux	60%	40%

Male

Female

100%

75%

50%

25%

25%

50%

75%

100%

Compare race at Invivoscribe vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Invivoscribe	50%	20%	8%	16%	7%	8.4
Bio-Techne	72%	7%	5%	13%	2%	9.1
B. Braun Medical	54%	21%	8%	12%	4%	9.9
Biomérieux	63%	11%	13%	9%	4%	9.8
Fresenius Kabi	56%	17%	11%	12%	4%	9.9
Immucor	53%	14%	21%	10%	3%	9.8

Invivoscribe and similar companies CEOs

CEOBio

Charles R. Kummeth

Bio-Techne

Charles Kummeth is a Board Member at DHR International, Board Member at BSN Medical, and Board Member at Gentherm and is based in Lake Elmo, Minnesota. He has worked as Board Member at SPARTON CORP, President/CEO at BIO-TECHNE CORP, and President Mass Spectrometry and Chromatography division at Thermo Fisher Scientific. Charles attended University of North Dakota between 1978 and 1983, Carlson School of Management between 1991 and 1993, and University of St. Thomas between 1987 and 1989.

Dwight Howard Egan

Co-Diagnostics

Dwight Egan is a President/CEO at CO-DIAGNOSTICS INC. He has worked as Board Member at Watermark Publishing Group, Inc.; Chairman/CEO/Co-Founder at BROADCAST INTERNATIONAL INC; and President/CEO at Watermark Publishing Group, Inc..

Jean-Claude Dubacher

B. Braun Medical

Jean-Claude Dubacher is Chairman and CEO of B. Braun of America Inc., which includes B. Braun Medical Inc., B. Braun Interventional Systems, Aesculap® and CAPS®. Mr. Dubacher joined B. Braun in August 2019 as President, B. Braun Medical Inc., and has served as Chairman and Chief Executive Officer of B. Braun Medical Inc. since January 1, 2020. Dubacher’s experience in healthcare spans more than 15 years in consulting and corporate roles including strategy, commercial, supply chain and manufacturing. Prior to joining B. Braun, Dubacher led commercial operations for the Surgical Ophthalmology Division of Johnson & Johnson (formerly Abbott Medical Optics) in Europe. Throughout his career, Mr. Dubacher has demonstrated a passion for focusing on customer needs and supporting people to be successful in developing, manufacturing, marketing, and selling products and services that benefit patients. Dubacher holds a Doctorate Degree in law (Dr. iur.) from the University of Zurich in Switzerland, and an MBA from Harvard Business School. He is a board member for the German American Chamber of Commerce.

Alexandre Mérieux

Biomérieux

Benjamin Manico

Ethicon

Dynamic, results-oriented leader with a strong track record of performance in turnaround and high-paced organizations. Utilize keen analysis and insights and team approach to drive organizational improvements and implementation of best practices. Superior interpersonal skills, capable of resolving multiple and complex (sales, human resources, legal, financial, operational) issues and motivating staff to peak performance. Excellent political connections developed as selected member of Fiorello LaGuardia's mayoral team.

John Ducker

Fresenius Kabi

John Ducker is a Plant Manager at Fresenius SE Group, President/CEO at Fresenius Kabi USA, and Director at FRANCESCA'S HOLDINGS CORP. He has worked as Board Member at FRESENIUS KABI ONCOLOGY LIMITED, President/CEO at App Pharmaceuticals Inc., and Board Member at Dabur Pharma Co. Ltd. John studied at University of Cambridge.

Avi Pelossof

Immucor

Avi Pelossof was appointed Global President of our infectious disease business unit in March 2013, after serving as Vice President of that business from February 2008 to February 2013. Mr. Pelossof joined Alere as Vice President, Blood-Borne Pathogens in January 2007 and served in that role until January 2008. Mr. Pelossof has more than 20 years of experience in diagnostics, global health and international finance, including senior roles at Chembio Diagnostic Systems, a manufacturer of diagnostic tests for infectious diseases, and Citigroup.

Tim Robinson

LGC Biosearch Technologies

Gregory J. Galvin

Rheonix

Gregory 'Greg' Galvin is a Co-Founder at Kionix Inc, Senior Investor at eQventure, and Advisory Board Member at USound GmbH and is based in New York City, New York. He has worked as President/CEO at Calient Technologies Inc, Dir:Corporate Rsch Relations at Cornell, and President/CEO at Kionix Inc. Gregory works or has worked as MEMBER at THE ITHACA'S SCIENCENTER, Board Member at Kionix Inc, and Trustee at Cornell. He studied at Cornell between 1980 and 1984, Caltech between 1975 and 1979, and Cornell between 1992 and 1993.

Stephane Bancel

Moderna

Stéphane Bancel (born 1972) is a French billionaire businessman. He is the chief executive officer (CEO) and a 9% owner of Moderna, an American biotechnology company.